Giesel, F.L.; Flechsig P.; Kuder T.; Schwartz L.; Wulfert S.; Zechmann C.; Bruchertseifer F.; Haberkorn U.; Kratochwil C.
(Experimental Oncology, 2013)
Aim - radiopeptide therapy with beta emitter labeled ¹⁷⁷Lu/⁹⁰Y- DOTA(0)-Phe(1)-Tyr(3)-octreotide (DOTATOC) and more recently also alpha emitting ²¹³Bi-DOTATOC are promising new treatments for neuroendocrine tumors. No early ...